Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

Training patients’ own immune cells to recognize and destroy hard-to-treat solid tumors


Children’s National Hospital’s Center for Cancer and Immunology Research, led by Catherine “Cath” Bollard, M.B.Ch.B., is forging new frontiers in cancer immunotherapy, which reprograms a patient’s own immune cells so they learn to recognize and destroy cancer cells – and just cancer cells. This short video explains the lab’s use of a novel immune-directed, T-cell therapy to treat high-risk children and young adults with solid tumors who have few therapeutic options and face uncertain futures. STAT editors chose this research paper as one of the finalists in STAT Madness 2020, a bracket-style competition to highlight the year’s best biomedical innovations.

Vote NOW for Children’s National!

About the Expert

Conrad Russell Cruz

Conrad Russell Y. Cruz

Director of the Translational Research Laboratories, Center for Emerging Technologies in Immune Cell Therapy

Invest in future cures for some of life's most devastating diseases

See other ways to give

Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.

Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you. Make it happen